Ceretype Neuromedicine
Ceretype is pioneering precision neuropsychiatry.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD11—16m (Dealroom.co estimates Jan 2024.)
Cambridge Massachusetts (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
N/A | Convertible | ||
| N/A | $2.3m | Seed | |
* | $100k | Seed | |
* | $2.0m | Seed | |
| Total Funding | CAD6.0m | ||